Activity of aztreonam in combination with novel β-lactamase inhibitors against metallo-β-lactamase-producing Enterobacterales from Spain-Reference-Cited by-同舟云学术

Activity of aztreonam in combination with novel β-lactamase inhibitors against metallo-β-lactamase-producing Enterobacterales from Spain

Published:2023-04 Issue:4 Volume:61 Page:106738
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Vázquez-Ucha Juan Carlos^ORCID,Alonso-Garcia Isaac^ORCID,Guijarro-Sánchez Paula^ORCID,Lasarte-Monterrubio Cristina^ORCID,Álvarez-Fraga Laura,Cendón-Esteve Arnau^ORCID,Outeda Michelle^ORCID,Maceiras Romina,Peña-Escolano Andrea^ORCID,Martínez-Guitián Marta,Arca-Suárez Jorge^ORCID,Bou Germán,Beceiro Alejandro

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference24 articles.

1. Epidemiology of β-lactamase-producing pathogens;Bush;Clin Microbiol Rev,2020

2. Therapeutic options for metallo-β-lactamase-producing Enterobacterales;Tan;Infect Drug Resist,2021

3. The revival of aztreonam in combination with avibactam against metallo-β-lactamase-producing Gram-negatives: a systematic review of in vitro studies and clinical cases;Mauri;Antibiotics,2021

4. New carbapenemase inhibitors: clearing the way for the β-lactams;Vázquez-Ucha;Int J Mol Sci,2020

5. Infectious Diseases Society of America 2022 guidance on the treatment of extended-spectrum β-lactamase producing Enterobacterales (ESBL-E), carbapenem-resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with difficult-to-treat resistance (DTR-P);Tamma;Clin Infect Dis,2022

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the activity of cefepime/enmetazobactam against Enterobacterales bacteria collected in Europe from 2019 to 2021, including third-generation cephalosporin-resistant isolates;Journal of Global Antimicrobial Resistance;2024-09

2. The contribution of porins to enterobacterial drug resistance;Journal of Antimicrobial Chemotherapy;2024-08-29

3. Practical Application of Aztreonam-Avibactam as a Treatment Strategy for Ambler Class B Metallo-β-Lactamase Producing Enterobacteriaceae;Antibiotics;2024-08-14

4. Impact of chromosomally encoded resistance mechanisms and transferable β-lactamases on the activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa;Journal of Antimicrobial Chemotherapy;2024-07-29

5. Novel partially reversible NDM-1 inhibitors based on the naturally occurring houttuynin;Bioorganic Chemistry;2024-06